Resources

Public and scientific interests have grown exponentially in recent years for the treatment of a variety of CNS disorders.  We are providing links to the information below,  for those who are interested in learning more about the emerging and rapidly evolving field of psychiatric medicine and our scientific team.

News - Press Releases - Articles

May 28, 2024 - World orphan drug congress - repurposing existing medicines
May 7, 2024 - appointment of Ray Kubacki as new board member
March 26, 2024 - LMI Announces the Publication of a Patent Application for Non-Hallucinogenic Psychedelic Fungi
February 27, 2024 - appointment of Dr. bert spilker as new board member
March 10, 2022 - President and Co-Founder of the Schultes Center for Amazonian Ethnobotanical Research Joins Luminous Mind Inc. Scientific Advisor Network
March 3, 2022 - Former Nature Genetics Chief Editor Joins the Research Team at Luminous Mind Inc. to Find Treatments for Psychiatric Illnesses

Select Publications by our team members

When it comes to magic mushrooms, less is more
Imaging in CNS Drug Discovery and Development
Mechanisms Underlying Unconscious Processing and Their Alterations in PTSD: Neuroimaging of Zero Monetary Outcomes Contextually Framed as “No Losses” vs. “No Gains”
Improving introspection to inform free will regarding the choice by healthy individuals to use or not use cognitive enhancing drugs
The Pain Imaging Revolution: Advancing Pain Into the 21st Century
Functional Neuroimaging of Reward Circuitry Responsivity to Monetary Gains and Losses in Posttraumatic Stress Disorder
March, 2022 - beating pain with psychedelics: matter over mind?
Use of functional imaging across clinical phases in CNS drug development
Alterations in brain structure and functional connectivity in prescription opioid-dependent patients